Lab
Laboratorio Clinico Sagrado Corazon, INC
Laboratorio Clinico Sagrado Corazon, INC was paid $466K by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 11% of everything it billed.
33Billing provider infoLABORATORIO CLINICO SAGRADO CORAZON, INC
SAN JUAN, PR 00926
SAN JUAN, PR 00926
33aNPI1073512315assigned 07/19/2005
33bProvider typeClinical Medical Laboratory
28Total paid$466K
24GClaims43,545
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#270 of 777
Median peer was paid$278K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,488 | $40K | |
| 2019 | 4,756 | $35K | |
| 2020 | 7,238 | $73K | |
| 2021 | 9,550 | $124K | |
| 2022 | 4,680 | $67K | |
| 2023 | 5,614 | $59K | |
| 2024incomplete | 6,219 | $69K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 4,189 | 3,940 | $52K |
| 80061 | Lipid panel | 11% | 4,334 | 4,075 | $50K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 10% | 1,934 | 1,752 | $47K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 10% | 1,505 | 1,362 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 7,690 | 6,970 | $47K |
| 80053 | Comprehensive metabolic panel | 8.1% | 4,715 | 4,387 | $38K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.9% | 1,040 | 960 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.7% | 2,049 | 1,943 | $17K |
| 81000 | 3.3% | 5,481 | 5,123 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 308 | 295 | $15K |
| 86328 | 3.2% | 818 | 746 | $15K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.8% | 256 | 240 | $13K |
28 more codes
| 84439 | 2.6% | 1,453 | $12K | |
| 87276 | 2.4% | 936 | $11K | |
| 87275 | 2.3% | 936 | $10K | |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 1,801 | $10K |
| 86738 | 2.1% | 817 | $10K | |
| 80050 | General health panel | 1.2% | 588 | $6K |
| 87088 | 1.1% | 707 | $5K | |
| 84153 | <1% | 221 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 480 | $3K |
| 82274 | <1% | 158 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 75 | $2K |
| 82043 | <1% | 205 | $1K | |
| 87899 | <1% | 174 | $1K | |
| 84436 | <1% | 110 | $629.31 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $472.96 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $454.29 |
| 84479 | <1% | 69 | $353.63 | |
| 85651 | <1% | 115 | $339.18 | |
| 85730 | <1% | 47 | $236.31 | |
| 82728 | <1% | 18 | $232.69 | |
| 84460 | <1% | 47 | $201.87 | |
| 84450 | <1% | 47 | $196.70 | |
| 86592 | <1% | 45 | $178.43 | |
| 82570 | <1% | 36 | $176.11 | |
| 85610 | <1% | 47 | $153.91 | |
| 82270 | <1% | 43 | $141.57 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $98.30 |
| 82947 | <1% | 12 | $38.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEBRON, MARIA (CLINICAL LABORATORY DIRECTOR)